Published in Science Translational Medicine · View the paper (DOI)
A bioengineered retinal implant, composed of human embryonic stem cells, has been shown to halt vision loss in advanced non-neovascular age-related macular degeneration. The implant was well-tolerated and successfully integrated with retinal tissue, demonstrating potential for a new therapy for this progressive disease.
Coverage from 2 institutions
- Retinal implant halts vision loss from macular degeneration American Association for the Advancement of Science (AAAS) · Apr 4, 2018 · first to report
- Treating vision loss University of California - Santa Barbara · Apr 4, 2018